BST1 and major depressive disorder: Dosage of the NaSSA mirtazapine was 1 mg/kg i.p. daily for 7 days, at which it ameliorated depression- and anxiety-like behaviors in CD157 KO mice, based on our preparatory experiments of the previous study (Lopatina et al., 2014).